• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Session 3: Discussant

Article

Jan Berger, MD, MJ, The American Journal of Pharmacy Benefits editor-in-chief, follows Rebecca Killon's remarks with her own insight on the importance of diabetes medication adherence.

Jan Berger, MD, MJ, The American Journal of Pharmacy Benefits editor-in-chief, follows Rebecca Killon’s remarks with her own insight on the importance of diabetes medication adherence.

“I've waited 13 years for adherence to be an important issue. In 2003, when I first got somebody's attention, they looked at me like I was crazy,” said Dr Berger. “It was just a matter of [what] doctors would say to us when we would share with them that their patient was nonadherent. ‘It's not my problem,’ ‘ It's not my fault,’ ‘ It's the patient, we told them what to do.‘“

Dr Berger argues that the only way to truly have a breakthrough, is in the power of physician-patient relationships and alignment. Through better communication, continual learning, and realistic expectations, we can improve adherence rates.

Related Videos
Beau Raymond, MD
Dr Kevin Mallow, PharmD, BCPS, BC-ADM, CDCES
Ian Neeland, MD
Chase D. Hendrickson, MD, MPH
Steven Coca, MD, MS, Icahn School of Medicine, Mount Sinai
Matthew Crowley, MD, MHS, associate professor of medicine, Duke University School of Medicine.
Susan Spratt, MD, senior medical director, Duke Population Health Management Office, associate professor of medicine, division of Endocrinology, Metabolism, and Nutrition,
Stephen Nicholls, MD, Monash University and Victorian Heart Hospital
Amal Agarwal, DO, MBA
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.